The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

If you would like to provide news about a coming event, just email harleytom20@gmail.com with the information and we will get ...

At the diabetes conference, Eli Lilly presented results of a phase 1 trial of its experimental drug, eloralintide. Unlike GLP ...

MariTide, a new drug from Amgen, helped some people with obesity lose up to 20% of their body weight. In a phase 2 trial, a new GLP-1 drug helped people lose up to 20% of their body weight over a year ...

A monthly weight loss drug from Amgen helped people lose about 20% of their body weight, according to the results of a phase ...

Biotech Metsera posts weight loss data for amylin analog, teeing up monthly GLP-1 combo plans By Nick Paul Taylor Jun 9, 2025 7:00am Metsera obesity drugs Clinical Data GLP-1 ...

What seems to be getting the most attention lately, however, are the number of people who have lost weight with certain medications. And the most popular ones are not pills. They are injections.

Shilpa Shetty avoids eating carbs after 7 PM to stay fit. A weight loss coach explains how this one habit alone can help you lose 3–4 kg in just a month.  ...

Yes! Independence Day is observed on Thursday, July 4, this year, and is considered a federal holiday. In total, 2025 has 12 ...

What’s interesting is that this drug is NOT approved by the Food and Drug Administration as a treatment for weight loss. It is approved for the treatment of Type 2 diabetes in adults.

Weight-loss surgery was shown to be five times more effective than weekly injections of popular GLP-1 receptor agonists, including semaglutide (such as Ozempic) and tirzepatide (such as Mounjaro).